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Sclerosing mesenteritis is primarily diagnosed through histologic and radiologic evalua-
tion; however, only a few works provide a systematic description using MRI. This work
presents the case of a 68-year-old male, who was admitted for a routine cholecystectomy.
Intraoperativly, a large mass was identified dislocating the abdominal viscera. The
microscopic examination revealed vascular congestion of the omentum. The contrast-
enhanced CT and MRI scans revealed the presence of a heterogenous, lipomatous mass
with lesions visible only in T2W and contrast-enhanced T1W MRI. Based on these findings,
the diagnosis of sclerosing mesenteritis was made. According to the available literature,
depending on the stage of sclerosing mesenteritis, different radiologic features are
encountered; however, it is possible that features from more than one form of the condi-
tion coexist in the same lesion. We therefore suggest that a combination of MRI sequences
should be acquired for a more accurate staging of the condition.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Sclerosing mesenteritis is a rare medical condition with just
over 1200 cases reported to date in the available literature [1];
however, it is believed that it is more common due to the fact
that in most cases, it is discovered incidentally, with a study
attributing a prevalence of 0.6% [2]. The termwas suggested by
Emory et al. [3], reflecting the fibrosis present in the lesions.
Sclerosing mesenteritis should not be considered a singlelared that no competing
(S. Apostolakis).
Elsevier Inc. under copy
se (http://creativecommoentity, but rather a spectrum of idiopathic primary inflam-
matory and fibrotic processes that affect the mesentery. Pri-
marily, three stages are distinguished (mesenteric
lipodystrophy, mesenteric panniculitis, and retractile mes-
enteritis), all with characteristic histopathologic and imaging
features.
Among the possible clinical presentations, the most com-
mon is abdominal pain (31.9%) followed byweight loss (21.3%),
nausea, and vomiting (11.7%) [4]. Other symptoms includeinterests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Fig. 1 e Axial CT scan with contrast demonstrating a
lipomatous lesion with ground glass appearance of the
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signs of gastrointestinal obstruction [5]. It is more common in
middle aged men (male to female ratio, 2:1; mean age of
diagnosis, 66.6 years) [4]. Sclerosing mesenteritis is a condi-
tion of unknown origin; nevertheless, its pathogenesis has
been associated with tuberculosis, pancreatitis, malignancies,
and granulomatous diseases [6,7], a theorywhich is supported
by themicroscopic findings, which suggest it to be the result of
injury to fat in themesentery [8]. Most importantly, sclerosing
mesenteritis has been linked to malignancy [2,6,9,10]; how-
ever, this is controversial [11].
Because of the nonspecific signs and symptoms of the
condition, diagnosis in themajority of cases ismade through a
combination of histopathologic and imaging findings. Most
available studies present the features of the condition using
CT. In the present article, a combination of CT andMRI images
is used to study a case of an unusually large mass in the
abdomen of a patient, with an ultimate goal to provide a
deeper understanding of the imaging features of the disease.mesenteric fat and linear opacities consistent with the
presence of vessels of the mesentery trapped inside the
mass (arrow).
Fig. 2 e Coronal T1W fat sat with contrast demonstrating
the extent of the lesion (arrow).Case report
A 68-year-old male with bouts of biliary colic because of
gallstones presents for a scheduled laparoscopic cholecys-
tectomy. He has a history of arterial hypertension and
paroxysmal atrial fibrillation, treated with irbesartan, meto-
prolol, ramipril, and acenocoumarol. On admission, he un-
derwent a thorough clinical and laboratory evaluation, which
was unremarkable.
During the operation, a sizeable part of the omentum with
several enlarged nodes was found to be tightly adhered to the
gallbladder, displacing the abdominal viscera to the right.
Hence, owing to the increased difficulty in the exposure of the
cystic duct and artery, the conversion to the open technique
was decided. The artery and the duct were safely ligated, and
the gallbladder was removed with no notable incidences
during the operation. In addition, a 5  4  2 cm specimen
from the omentum was sent for microscopic examination.
Based on the macroscopic findings and before the acqui-
sition of the biopsy results, a postoperative evaluation of the
mass was decided. The patient underwent contrast-enhanced
abdominal CT and MRI scan. For the latter case, T1 and T2
weighted images were acquired using a 1.5-T scanner. The
recovery of the patient was uneventful with dismissal on
postoperative day 9.
The patient provided a written informed consent for the
release of his case history and of the visual material published
in the present article.
The microscopic examination revealed vascular conges-
tion of the omentum. The enhanced CT scan revealed the
presence of an extensive area of a lipomatous density mass
that contained linear opacities consistentwith the presence of
vessels of the mesentery trapped inside the mass (Fig. 1). In
addition, ground glass opacity of the mesentery fat was
observed (misty mesentery). The MRI that was subsequently
performed identified an inhomogeneous, intraperitoneal
mass extending from about the middle of the spleen until the
left iliac fossa, measuring 34  23  18 cm (Fig. 2), causing arightward dislocation of the intestine. No enlarged lymph
nodes were identified.
The mass appears with increased signal intensity in T1W
and T2W images and with signal suppression in T2W fat
saturated images, suggesting the lipomatous composition of
the mass. With the exception of the T1W without contrast, in
all the remaining axial images can be identified two round
lesions of maximum diameter of 2 cm with well-defined bor-
ders inside themass (arrowheads Fig. 3). These lesions appear
with intermediate signal intensity in T1W and increased
signal in T2W and are enhanced by the contrast especially in
their periphery during late phase. A third lesion which is
Fig. 3 e T1- (left column) and T2-weighted (right column) images of the lesion with (middle row) or without (top row)
contrast medium or with fat saturation (bottom row). All images demonstrate the area of interest at approximately the same
level. Arrowheads demonstrate two lesions visible in all images, whereas black arrow shows a lesion visible only in T2W
images.
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these findings, the diagnosis of sclerosing mesenteritis was
made.
No specific treatment was administered. The patient was
reevaluated clinically in postoperative months 3, 6, 9, and
with an abdominal MRI scan in postoperative month 6,
without any significant differentiations.Discussion
In the present article, we report the radiologic findings from
the systematic investigation of a patient with sclerosing
mesenteritis presenting as a large abdominal mass. Depend-
ing on the histologic findings, three main subtypes are
distinguished. The first stage (mesenteric lipodystrophy) is
characterized predominantly by fat necrosis and infiltration of
the mass by lipid-filled macrophages, followed by intense in-
flammatory reaction with lymphocytic infiltrates and lipid
cystic necrosis (mesenteric panniculitis). Finally, in what isregarded as the end stage of the disease (retractile mesen-
teritis), shortening of the mesentery, diffuse fibrosis with po-
tential calcifications, and giant multinucleated cells are
encountered [12,13]. It is believed that in most cases, all three
stages are present simultaneously but to different extents [14].
Although the diagnosis is established through histologic
examination, there are some radiologic features that can
provide adequate evidence for safe recognition of this condi-
tion. These include density of fat tissue in CT, dislocation of
bowel loops, preservation of fat around themesenteric vessels
and soft tissue nodules (“fat-ring sign”), soft-tissue sur-
rounding the inflamed mass (“tumoral pseudocapsule”), and
scattered lymph nodes throughout the mass [15]. Finally, the
mass ismost frequently located at the left side, corresponding
to the jejunal mesentery [2].
Moreover, each stage has a different presentation on MRI.
Mesenteric panniculitis is characterized by hyperintense
signal on T2W fat sat, suggesting the presence of edema [16].
In retractile mesenteritis on the other hand, the mass dem-
onstrates intermediate signal density with multiple strands
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scans and hypointense signal on T2W with delayed hyper-
enhancement when fibrosis is prevalent [14]. Scattered low
signal areas correspond to calcification [17].
In our case, abdominal MRI demonstrates the presence of a
heterogeneous mass with hypo and hyperintense areas and
multiple strands, consistent with the presence of vessels of
the mesentery trapped inside the mass. In the T2W images
(with and without fat sat), three nodules are apparent, two
hypointense and one hyperintensewith a central hypointense
area that are not visible in the T1W. Interestingly, the two
hypointense nodules demonstrate peripheral late phase
enhancement, which is suggestive of fibrosis. In addition, the
most dorsal of these nodules presents as a hyperintense
nodule with a hypointense halo in T2 fat-suppressed images.
Hence, at a given time,more than one subtype of the condition
can be present.
When asymptomatic, patients require no treatment either
pharmacologic or surgical, as most cases regress spontane-
ously. In the rest of cases, corticosteroids alone or in combi-
nation with immunosuppressants (e.g., tamoxifen,
cyclophosphamide) have demonstrated good efficiency in
symptomatic patients [18].
In conclusion, provided that contrast-enhanced CT and
T1W MRI scans provide inadequate information about the
stage of the condition, it is suggested that each case is eval-
uated with a combination of sequences, primarily T2W and
contrast-enhanced T1W MRI, which demonstrate a higher
sensitivity in the detection of lesions.Acknowledgments
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